Predictive potential of glutathione S-transferase polymorphisms for prognosis of osteosarcoma patients on chemotherapy

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 6, 2012, Pages 2705-2709

  Zhang, Shai Lin ^a   Mao, Ning Fang ^b   Sun, Jun Ying ^a   Shi, Zhi Cai ^b   Wang, Bing ^a   Sun, Yong Jian ^c  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Gsts; Osteosarcoma; Polymorphisms; Predictive role

Indexed keywords

EID: 84874061870     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.6.2705     Document Type: Article

References (39)

1. Ali-Osman F, Akande O, Antoun G, et al (1997). Molecular cloning, characterization, and expression in Escherichia coli of full length cDNAs of three human glutathione S-transferase pi gene variants. J Biol Chem, 272, 10004-12.
2. Ambrosone CB, Freudenheim JL, Graham S, et al (1995). Cytochrome P450 1A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res, 55, 3483-5.
3. Beeghly A, Katsaros D, Chen H, et al (2006). Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecol Oncol, 100, 330-7.
4. Bell DA, Taylor J, Paulson DF, et al (1993). Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst, 85, 1159-64.
5. Black SM, Beggs JD, Hayes JD, et al (1990). Expression of human glutathione S-transferase in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil. Biochem J, 268, 309-15.
6. Board PG, Webb GC, Coggan M (1989). Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 gene to chromosome bands 11q13 and 12q13-14. Ann Hum Genet, 53, 205-13.
7. Choueiri TK, Garcia JA, Elson P, et al (2007). Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. Cancer, 110, 543-50.
8. Deakin M, Elder J, Hendrickse C, et al (1996). Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis, 17, 881-4.
9. Fuchs B, Zhang K, Schabel A, et al (2001). Identification of twenty-two candidate markers for human osteogenic sarcoma. Gene, 278, 245-52.
10. Harries LW, Stubbins MJ, Forman D, et al (1997). Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis, 18, 641-4.
11. Helzlsouer KJ, Selmin O, Huang H-Y, et al (1998). Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst, 90, 512-8.
12. Hengstler JG, Arand M, Herrero ME, et al (1998). Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase, and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res, 154, 47-85.
13. Howells RE, Dhar KK, Hoban PR, et al (2004). Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer. Int J Gynecol Cancer, 14, 242-50.
14. Ishimoto TM, Ali-Osman F (2002). Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. Pharmacogenetics, 12, 543-53.
15. Kelsey KT, Hankinson SE, Colditz GA, et al (1997). Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases. Cancer Epidemiol Biomarkers Prev, 6, 511-5.
16. Ketterer B (1988). The protective role of glutathione transferases in mutagenesis and carcinogenesis. Mutat Res, 202, 343-61.
17. Lee JM, Wu MT, Lee YC, et al (2005). Association of GSTP1 polymorphism and survival for esophageal cancer. Clin Cancer Res, 11, 4749-53.
18. Limmahakhun S, Pothacharoen P, Theera-Umpon N,et al (2011). Relationships between serum biomarker levels and clinical presentation of human osteosarcomas. Asian Pac J Cancer Prev, 12, 1717-22.
19. Listowsky I (1993). High capacity binding by glutathione S-tranferases and glucocorticoid resistance. In: Tew KD, Pickett CB, Mantle TJ, Mannervik B, Hayes JD, eds. Structure and Function of Glutathione Transferases. Boca Raton, FL: CRC Press, 199.
20. Lo HW, Ali-Osman F (1997). Genomic cloning of hGSTP1*C, an allelic human Pi class glutathione S-transferase gene variant, and functional characterization of its retinoic acid response elements. J Biol Chem, 272, 32743-9.
21. Lu XF, Yang WL, Wan ZH, et al (2011). Glutathione S-transferase polymorphisms and bone tumor risk in China. Asian Pac J Cancer Prev, 12, 3357-60.
22. Mannervik B, Awasthi YC, Board PG, et al (1992). Nomenclature for human glutathione transferases. Biochem J, 282, 305-6.
23. Marsh S, Paul J, King CR, et al (2007). Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer. J Clin Oncol, 25, 4528-35.
24. McIlwain CC, Townsend DM, Tew KD (2006). Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene, 25, 1639-48.
25. Nagle CM, Chenevix-Trench G, Spurdle AB, et al (2007). The role of glutathione-S-transferase polymorphisms in ovarian cancer survival. Eur J Cancer, 43, 283-90.
26. Nakagawa K, Saijo N, Tsuchida S, et al (1990). Glutathione S-transferase p as a determinant of drug resistance in transfectant cell lines. J Biol Chem, 265, 4296-301.
27. Nazar-Stewart V, Motulsky AG, Eaton DL, et al (1993). The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res, 53, 2313-8.
28. Oldenburg J, Kraggerud SM, Cvancarova M, et al (2007). Cisplatin-induced long-term hearing impairment is associated with specific glutathione S-transferase genotypes in testicular cancer survivors. J Clin Oncol, 25, 708-14.
29. Pemble S, Schroeder KR, Spencer SR, et al (1994). Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J, 300, 271-6.
30. Rosen G, Murphy ML, Huvos AG, et al (1976). Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer, 37, 1-11.
31. Seidegard J, Pero RW, Markowitz MM, et al (1990). Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis, 11, 33-6.
32. Seidegard J, Vorachek WR, Pero RW, et al (1988). Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA, 85, 7293-7.
33. Stoehlmacher J, Park DJ, Zhang W, et al (2002). Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst, 94, 936-42.
34. Strange RC, Matharoo B, Faulder GC, et al (1991). The human glutathione S-transferases: a case-control study of the incidence of the GST1 theta phenotype in patients with adenocarcinoma. Carcinogenesis, 12, 25.
35. Tew KD (1994). Glutathione-associated enzymes in anticancer drug resistance. Cancer Res, 54, 4313-20.
36. Wang X, Zuckerman B, Pearson C, et al (2002). Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA, 287, 195-202.
37. Watson MA, Stewart RK, Smith GBJ, et al (1998). Human glutathione S-transferase P1 polymorphisms: relationships to lung tissue enzyme activity and population frequency distribution. Carcinogenesis, 19, 275-80.
38. Yuan Z-M, Smith PB, Brundrett RB, et al (1991). Glutathione conjugation with phosphoramide mustard and cyclophosphamide. Drug Metab Dispos, 19, 625-9.
39. Zimniak P, Nanduri B, Pikula S, et al (1994). Naturally occurring human glutathione S-transferase GSTP-1 isoforms with isoleucin and valine in position 104 differ in enzymic properties. Eur J Biochem, 224, 893-9.